Obesity, endogenous hormone metabolism, and prostate cancer risk: a conundrum of "highs" and "lows"
- PMID: 20179295
- DOI: 10.1158/1940-6207.CAPR-10-0014
Obesity, endogenous hormone metabolism, and prostate cancer risk: a conundrum of "highs" and "lows"
Abstract
This perspective on the report by Neuhouser et al. (beginning on page 279 in this issue of the journal) examines the associations that have been observed between body mass index, serum insulin, preexisting diabetes, androgen metabolism, and prostate cancer risk. Based on data of the Prostate Cancer Prevention Trial, the observations by Neuhouser et al. plus findings from other studies suggest a complex mix of higher and lower risks for high- and low-grade cancer in association with obesity and endogenous hormone metabolism.
Comment on
-
Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.Cancer Prev Res (Phila). 2010 Mar;3(3):279-89. doi: 10.1158/1940-6207.CAPR-09-0188. Epub 2010 Feb 23. Cancer Prev Res (Phila). 2010. PMID: 20179296 Free PMC article. Clinical Trial.
Similar articles
-
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1977-83. doi: 10.1158/1055-9965.EPI-06-0477. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035408 Clinical Trial.
-
The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.J Steroid Biochem Mol Biol. 2004 Nov;92(4):237-53. doi: 10.1016/j.jsbmb.2004.10.002. Epub 2005 Jan 5. J Steroid Biochem Mol Biol. 2004. PMID: 15663987 Review.
-
Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):63-9. doi: 10.1158/1055-9965.EPI-06-0754. Epub 2006 Dec 19. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17179486
-
Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging.Urology. 2004 Feb;63(2):253-8. doi: 10.1016/j.urology.2003.09.060. Urology. 2004. PMID: 14972466
-
Obesity and prostate cancer.Can J Urol. 2006 Apr;13 Suppl 2:11-7. Can J Urol. 2006. PMID: 16672123 Review.
Cited by
-
Pilot Study on the Locoregional Demographics of Prostate Cancer in River State, Nigeria.Niger Med J. 2022 May 28;62(6):340-345. doi: 10.60787/NMJ-62-6-65. eCollection 2021 Nov-Dec. Niger Med J. 2022. PMID: 38736520 Free PMC article.
-
Epidemiology of Prostate Cancer.World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20. World J Oncol. 2019. PMID: 31068988 Free PMC article. Review.
-
Metabolic imbalance and prostate cancer progression.Int J Mol Epidemiol Genet. 2010 Jul 25;1(4):248-71. Int J Mol Epidemiol Genet. 2010. PMID: 21532839 Free PMC article.
-
Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis.Nutrients. 2012 Nov 6;4(11):1650-63. doi: 10.3390/nu4111650. Nutrients. 2012. PMID: 23201838 Free PMC article. Clinical Trial.
-
Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.Am J Epidemiol. 2012 Dec 15;176(12):1121-9. doi: 10.1093/aje/kws191. Epub 2012 Nov 28. Am J Epidemiol. 2012. PMID: 23193118 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical